QT Prolongation After Minor Head Trauma in a Pediatric Patient

We report a case of QTc prolongation associated with mild concussion in a pediatric patient. An 11-year-old male presented to the emergency department after sustaining a head injury during football practice. He complained of headache and blurry vision. Physical examination was within normal apart from an irregular heart rhythm. Electrocardiogram (ECG) showed normal sinus rhythm with QTc (Bazett formula) 460  ms. The patient was diagnosed with concussion and referred for cardiology follow-up of the QTc. ECG the next day showed QTc 462 ms (heart rate 105 bpm) supine and 494 ms after suddenly standing up (heart rate 120 bpm). Family history was negative for sudden cardiac events. Exercise stress test ing 1 week later showed a baseline QTc 462 ms and 488 ms at 4 min into recovery. Holter monitoring showed evidence of increased parasympathetic activity manifested by marked sinus arrhythmia. Repeated ECG, exercise stress testing, and Holter monitoring 3 months later showed normalized QTc value s. His concussion symptoms were resolved at the time of repeat testing. Mild head trauma/concussion could be associated with prolonged QTc and abnormal cardiac repolarization. While these changes seem to be self-limiting, they remain a possible substrate for malignant arrhythmias. Recognition of the se changes would lead to appropriate reassurance and/or precautions in the acute setting, especially in at-risk populations such as long QT syndro...
Source: Pediatric Cardiology - Category: Cardiology Source Type: research

Related Links:

A 48-year-old kidney transplant recipient was admitted to our hospital with nausea, polyuria, diffuse paresthesia, and muscle weakness of all extremities. His past medical history was remarkable for renal transplantation with impaired graft function (baseline glomerular filtration rate approximately 20 ml/min per 1.73 m2) and parathyroidectomy due to an uncontrolled hyperparathyroidism. An electrocardiogram showed pronounced concave ST-segment elevations in leads II, III, and aVF suspicious of an acute ST elevation myocardial infarction as well as ascending elevations deriving from a deep S wave especially in leads V1 &nda...
Source: Kidney International - Category: Urology & Nephrology Authors: Tags: Nephrology Image Source Type: research
Final results from the ACHIEVE II randomized, placebo-controlled trial confirm the safety and efficacy of the CGRP antagonist for acute migraine. FDA action is expected next month.Medscape Medical News
Source: Medscape FamilyMedicine Headlines - Category: Primary Care Tags: Neurology & Neurosurgery News Source Type: news
Conditions:   Migraine With Aura;   Migraine;   Migraine Without Aura;   Connective Tissue Diseases Interventions:   Other: Connective Tissue Massage;   Other: Education Sponsor:   Ankara Yildirim Beyazıt University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Neck Pain;   Headache;   Musculoskeletal Diseases;   Adherence, Patient;   Absenteeism;   Workplace;   Health Promotion;   Ergonomics;   Efficiency;   Presenteeism;   Occupational Health;   Surveys and Questionnaires;   Adult;   Exercise Therapy;   Work Performance Interventions:   Other: Multi-component intervention;   Other: Control Sponsors:   Zurich University of Applied Sciences;   Swiss National Science Foundation Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Publication date: Available online 19 November 2019Source: Pharmacological ResearchAuthor(s): Nebojša Mujović, Dobromir Dobrev, Milan Marinković, Vincenzo Russo, Tatjana S. PotparaAbstractAmiodarone is an iodinated benzofuran derivative, a highly lipophilic drug with unpredictable pharmacokinetics. Although originally classified as a class III agent due to its ability to prolong refractoriness in cardiac regions and prevent/terminate re-entry, amiodarone shows antiarrhythmic properties of all four antiarrhythmic drug classes. Amiodarone is a potent coronary and peripheral vasodilator and can be safely used in pati...
Source: Pharmacological Research - Category: Drugs & Pharmacology Source Type: research
Authors: Kaneko K, Chikamoto A, Hsu JC, Tochinai R, Sekizawa SI, Yamamoto M, Kuwahara M Abstract Environmental enrichment (EE) can reduce anxiety and stress in experimental animals, while little is known about the influence on autonomic nervous activity especially in disease animal models. Diabetes mellitus (DM) is associated with cardiovascular autonomic dysfunction, which can be characterized by a higher resting heart rate and a lower heart rate variability (HRV). We hypothesized that EE can enhance parasympathetic nervous activity while reducing disease progression in type 2 diabetic mice. A telemetry transmitte...
Source: Experimental Animals - Category: Research Tags: Exp Anim Source Type: research
The drug, ubrogepant, relieved migraine pain within two hours for a fifth of people given it in a large-scale clinical trial led by Montefiore Headache Center in New York.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
ConclusionAMI as a result of penetrating trauma is rare, but can occur secondary to an acute thrombus, even in the absence of a direct cardiac injury. MI should be a consideration in patients with penetrating trauma to the chest, regardless of the intensity of the trauma. At minimum, a 12-lead electrocardiogram (ECG) and a baseline troponin should be obtained at initial evaluation and post-operatively, if surgically managed. If ECG demonstrates findings concerning for MI, it should be followed with an echocardiogram and/or cardiac angiogram to further help guide management, with an early cardiology consultation.
Source: International Journal of Surgery Case Reports - Category: Surgery Source Type: research
(University of Illinois at Chicago) Researchers have discovered that a peptide links together migraine pain and pain induced by opioid overuse.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
The most common treatment against migraine is unsafe for people at risk of cardiovascular disease and stroke, but a new drug against migraine has shown promise in a large-scale clinical trial, offering hope of an alternative treatment.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news
More News: Arrhythmia | Cancer & Oncology | Cardiology | Concussion | Electrocardiogram | Emergency Medicine | Head Injury | Headache | Heart | Long QT Syndrome | Migraine | Pediatrics | Sports Medicine